Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice
about
Treatment Challenges and Survival Analysis of Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Real World.Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer.Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort.Atypical breast adenosquamous carcinoma following acute myeloid leukemia in a middle-aged woman: A case report.Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin.
P2860
Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Survival in patients with non- ...... astuzumab in clinical practice
@en
type
label
Survival in patients with non- ...... astuzumab in clinical practice
@en
prefLabel
Survival in patients with non- ...... astuzumab in clinical practice
@en
P2093
P2860
P1433
P1476
Survival in patients with non- ...... astuzumab in clinical practice
@en
P2093
Anthony Masaquel
Brian Barnett
Christopher M Gallagher
Elizabeth Butts
Kenneth More
Marjolaine Gauthier-Loiselle
Nicholas Sicignano
Raluca Ionescu-Ittu
Roy Nitulescu
Tripthi Kamath
P2860
P2888
P356
10.1186/S40064-016-2008-9
P577
2016-03-31T00:00:00Z
P5875
P6179
1039085606